US HB4106 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on July 30 2019 - 25% progression, died in committee
Action: 2019-07-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 30 2019 - 25% progression, died in committee
Action: 2019-07-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
Title
Responsibility in Drug Advertising Act of 2019
Sponsors
| Rep. Rosa DeLauro [D-CT] | Rep. Ro Khanna [D-CA] | Rep. Raul Grijalva [D-AZ] | Rep. Christopher Pappas [D-NH] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-07-31 | House | Referred to the Subcommittee on Health. |
| 2019-07-30 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-07-30 | House | Introduced in House |
Same As/Similar To
HB2452 (Related) 2019-05-31 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
SB3180 (Same As) 2020-01-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3180 (Same As) 2020-01-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Drug safety, medical device, and laboratory regulation
Health
Marketing and advertising
Prescription drugs
Health
Marketing and advertising
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/4106/all-info |
| Text | https://www.congress.gov/116/bills/hr4106/BILLS-116hr4106ih.pdf |
